Clinical trial
NAD+ Oral Supplement Pilot Intervention in Adult Females
NCT06579209 is registered in ClinicalTrials.gov with University of Rhode Island as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NAD+ Oral Supplement Pilot Intervention in Adult Females
- Lead sponsor
- University of Rhode Island
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 1, 2024
- Completion date
- February 20, 2026
- Enrollment
- 53 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive change, inflammation, neurodegenerative diseases